Purchase Order 75N92B25P00263
Award Date 9/19/25
Potential Completion Date 9/18/26
Potential Value $24K
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit biotechnology company headquartered in Pleasanton, California. The $24,861.50 firm-fixed-price purchase order contract has an ultimate completion date of August 20, 2026. The contract does not have a set-aside designation. 10X Genomics specializes in advanced genomic analysis...
- The National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $10,158 firm fixed price purchase order to 10X Genomics, Inc. for products and services to be delivered between July 2023 and July 2024. 10X Genomics, headquartered in Pleasanton, California, will provide genomic analysis tools and technologies to support NIH research initiatives. No subcontractors or set aside designations were indicated. This purchase augments NIH's ongoing...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed-price BPA (Blanket Purchase Agreement) call valued at $24,339 to 10X Genomics, Inc. on September 15, 2025, with completion scheduled for September 14, 2026. The contract procures two specialized genomic analysis products: Chromium Next GEM Chip H Single Cell Kit (16 reactions) and Chromium Next GEM Single Cell ATAC Kit V2 (16 reactions), both sourced from quotes referenced as SQ3272383V1. The award...
- This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $24,324 firm fixed-price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc. on April 13, 2022, with completion targeted for January 31, 2024. The award covers Chromium Next GEM Single Cell 3' Kit V3.1 consumables (16 reactions), specialized reagent kits used for advanced single-cell transcriptomics research. This procurement was executed without a set-aside designation and represents a call against an...
- This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $17,332.00 contract is for the delivery of 10X Genomics' products and services for single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, and support services. The contract has a period of...
- On April 13, 2022, the National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $20,058.50 Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc., a Pleasanton, California-based biotechnology company specializing in genomic analysis platforms and reagents. This firm fixed-price contract, which was completed by January 31, 2024, procures specialized single-cell genomics consumables and kits essential for advanced molecular research. The specific deliverables include...
- This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation. 10X Genomics is providing specialized scientific equipment,...
- 10X Genomics, Inc. received a $24,970 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health, on April 13, 2022. This award, designated as a Blanket Purchase Agreement (BPA) call under contract number 23-002229, procures specialized genomic research consumables including Chromium Next GEM Single Cell Fixed RNA Sample Preparation Kits, Chromium Fixed RNA Kits for human transcriptome...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $185,142.00 firm fixed price purchase order to 10X Genomics, Inc. for reagents compatible with the company's Chromium Controller single cell platform. The contract has a completion date of October 30, 2020 and does not utilize a set-aside designation. 10X Genomics is a life sciences technology company that specializes in products and...